Generation and characterization of a TRIM21 overexpressing mouse line
TRIM21 过表达小鼠系的生成和表征
基本信息
- 批准号:9807181
- 负责人:
- 金额:$ 8.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-08-15 至 2021-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAntibodiesAntisense OligonucleotidesBacteriaBindingBinding ProteinsBiologyCRISPR/Cas technologyCellsCommunitiesCultured CellsEmbryoFc ReceptorFertilizationFinancial compensationFutureGenerationsGenesIn VitroInjectionsKnock-in MouseKnock-outKnockout MiceKnowledgeMessenger RNAMetaphaseMethodsMusNeuronsOocytesPathway interactionsPhysiological ProcessesProcessProteinsRNARNA InterferenceResearchSNAP23 geneSiteTechniquesTestingTimeTissuesTransgenic MiceTranslationsWorkbasecell typeclinical developmentdesignegginfertility treatmentinterestmulticatalytic endopeptidase complexoocyte maturationoverexpressionpromoterprotein degradationprotein functionrecruittoolubiquitin-protein ligasevector
项目摘要
SUMMARY/ABSTRACT
Specific depletion of proteins is critical for the study of oocyte/egg/embryo biology, but commonly
used methods for protein depletion often have limitations due to protein stability and/or compensatory
mechanisms. The objective of this project is to generate and characterize a mouse line that contains
an oocyte-specific, constitutively-expressing TRIM21 gene. TRIM21 is an intracellular antibody
receptor and E3 ubiquitin ligase that binds to an antibody within the cell. It then recruits the
proteasome to the antibody-bound protein, where the protein of interest is degraded through the
proteasome pathway. This process occurs very rapidly and thus is a specific method for acutely
depleting proteins that are abundant and stable. Although TRIM21 is expressed to varying degrees in
diverse tissues, it needs to be overexpressed in oocytes and eggs. This is accomplished by
microinjecting RNA encoding TRIM21, followed by a subsequent injection of an antibody specific for
the protein to be degraded. It would be highly advantageous to have a mouse that constitutively
expresses TRIM21 protein in oocytes and eggs, such that isolated immature oocytes or mature eggs
would only need to be injected once, with antibody, rather than twice, with RNA and then antibody.
The mouse we propose to make will express TRIM21 specifically in oocytes; however, the founder
mice could be bred to mice expressing other tissue-specific Cres, so this mouse will benefit not only
other labs studying oocytes and eggs, but the broader scientific community as well. Aim 1 will
generate this mouse using CRISPR/Cas9. The targeting vector will contain a CAG promoter followed
by a LoxP-STOP-LoxP sequence and then the TRIM21 sequence, tagged with HA. This construct
will be guided into the Rosa26 locus, a safe harbor site that has been widely used for overexpressing
genes. Founder mice will be bred with Zp3-Cre mice to place the CAG promoter directly in front of
the TRIM21 to obtain constitutive overexpression of TRIM21, containing an HA tag, in oocytes and
eggs. Aim 2 will characterize the TRIM21 knock-in mice by performing tests to confirm that oocytes
and eggs reliably express functional TRIM21. This mouse will be useful for studies of relatively short-
lived cells such as oocytes and eggs and will be invaluable for studies of oocyte maturation and
fertilization. It can also be used to produce other tissue-specific knock-ins so will be a generally
useful tool for other labs as well.
摘要/摘要
蛋白质的特异性耗竭对于研究卵母细胞/鸡蛋/胚胎生物学至关重要,但通常
蛋白质消耗的使用方法通常由于蛋白质稳定性和/或代偿性而具有局限性
机制。该项目的目的是生成和表征包含的鼠标线
卵母细胞特异性表达的TRIM21基因。 TRIM21是一种细胞内抗体
受体和E3泛素连接酶与细胞内的抗体结合。然后招募
抗体结合蛋白的蛋白酶体,其中感兴趣的蛋白质通过
蛋白酶体途径。这个过程非常迅速地发生,因此是一种急性的特定方法
耗尽丰富且稳定的蛋白质。尽管TRIM21在不同程度上表示
多种组织,需要在卵母细胞和卵中过表达。这是由
微注射编码TRIM21的RNA,然后随后注入特定于特异的抗体
要降解的蛋白质。拥有组成性的鼠标将非常有利
表达卵母细胞和卵中的TRIM21蛋白
只需要用抗体注射一次,而不是用RNA和抗体注射两次。
我们提出的小鼠将在卵母细胞中专门表达TRIM21。但是,创始人
可以将小鼠饲养到表达其他组织特异性CRE的小鼠中,因此该鼠标不仅会受益
其他研究卵母细胞和鸡蛋的实验室,但也是更广泛的科学界。目标1意志
使用CRISPR/CAS9生成此鼠标。靶向矢量将包含一个CAG启动子
通过loxp-stop-loxp序列,然后是用ha标记的trim21序列。这个结构
将引导到Rosa26基因座,这是一个安全港口,已广泛用于过表达
基因。创始人小鼠将用ZP3-CRE小鼠育成,将CAG启动子直接放在
trim21获得oocytes中包含ha标签的trim21的本构过表达
鸡蛋。 AIM 2将通过执行测试来确认卵母细胞来表征TRIM21敲入小鼠
卵可靠地表达功能性TRIM21。该小鼠将有助于研究相对较短的研究
生存的细胞,例如卵母细胞和卵,对于卵母细胞的成熟和
受精。它也可以用于生产其他组织特异性的敲击ins,因此通常是
其他实验室也有用的工具。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LISA M MEHLMANN其他文献
LISA M MEHLMANN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LISA M MEHLMANN', 18)}}的其他基金
Signaling mechanisms that regulate meiosis in mammalian oocytes
调节哺乳动物卵母细胞减数分裂的信号机制
- 批准号:
7478706 - 财政年份:2007
- 资助金额:
$ 8.2万 - 项目类别:
Signaling mechanisms that regulate meiosis in mammalian oocytes
调节哺乳动物卵母细胞减数分裂的信号机制
- 批准号:
8109938 - 财政年份:2007
- 资助金额:
$ 8.2万 - 项目类别:
Signaling mechanisms that regulate meiosis in mammalian oocytes
调节哺乳动物卵母细胞减数分裂的信号机制
- 批准号:
7616729 - 财政年份:2007
- 资助金额:
$ 8.2万 - 项目类别:
Signaling mechanisms that regulate meiosis in mammalian oocytes
调节哺乳动物卵母细胞减数分裂的信号机制
- 批准号:
7301264 - 财政年份:2007
- 资助金额:
$ 8.2万 - 项目类别:
Signaling mechanisms that regulate meiosis in mammalian oocytes
调节哺乳动物卵母细胞减数分裂的信号机制
- 批准号:
7810563 - 财政年份:2007
- 资助金额:
$ 8.2万 - 项目类别:
Regulation of Meiotic Arrest in Oocytes by G-Proteins
G 蛋白对卵母细胞减数分裂停滞的调节
- 批准号:
6758536 - 财政年份:2003
- 资助金额:
$ 8.2万 - 项目类别:
相似国自然基金
人源化小鼠筛选猴痘抗体及机制研究
- 批准号:82373778
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
抗HTNV抗体mRNA修饰MSC在肾综合征出血热治疗中的作用研究
- 批准号:82302487
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
人和小鼠中新冠病毒RBD的免疫原性表位及其互作抗体的表征和结构组学规律的比较研究
- 批准号:32371262
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
靶向肿瘤内T细胞的双特异性抗体治疗策略研究
- 批准号:82371845
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
靶向DLL3和γδ T细胞的双特异抗体对小细胞肺癌的免疫治疗活性研究
- 批准号:32300783
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Targeting HNF4-induced thrombo-inflammation in Chagas disease
针对恰加斯病中 HNF4 诱导的血栓炎症
- 批准号:
10727268 - 财政年份:2023
- 资助金额:
$ 8.2万 - 项目类别:
A novel peptide assay for hepcidin clinical monitoring
一种用于铁调素临床监测的新型肽测定方法
- 批准号:
10698746 - 财政年份:2023
- 资助金额:
$ 8.2万 - 项目类别:
Cardiac Macrophages as Disease Drivers in Chronic Ischemic Heart Failure
心脏巨噬细胞作为慢性缺血性心力衰竭的疾病驱动因素
- 批准号:
10228245 - 财政年份:2021
- 资助金额:
$ 8.2万 - 项目类别:
Cardiac Macrophages as Disease Drivers in Chronic Ischemic Heart Failure
心脏巨噬细胞作为慢性缺血性心力衰竭的疾病驱动因素
- 批准号:
10592811 - 财政年份:2021
- 资助金额:
$ 8.2万 - 项目类别:
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
- 批准号:
10451498 - 财政年份:2020
- 资助金额:
$ 8.2万 - 项目类别: